What is the long-term trend for CareDx's contingent consideration fair value adjustments?

Over 2 years (2023 to 2025), CareDx's contingent consideration fair value adjustments has grown at a -48.8% compound annual growth rate (CAGR), from $2.68M to $703K.

CareDx CDNA Contingent consideration fair value adjustments

Contingent consideration fair value adjustments at other companies

Natera, Inc.NTRA

——

VeracyteVCYT

——

RevvityRVTY

——

Other financials

Income statement

See full

Revenue$117.7M+39.0%

Operating income$1.2M+109%

Net income$2.8M+127%

EPS (diluted)$0.05+126%

Balance sheet

See full

Cash & equivalents$78.5M-12.1%

Total debt$24.5M-19.1%

Total equity$313.5M-17.3%

Total assets$411.1M-16.0%

Cash flow

See full

Operating cash flow$4.3M+116%

CapEx$3.8M+134%

Free cash flow$514.0K+102%

Valuation

See full

Market cap$1.4B+32.2%

Enterprise value$1.35B+34.6%

P/S3.4×+0.3×

Profitability

See full

Gross margin65.5%—

Operating margin-3.9%-18.3pp

Net margin-2%-19.9pp

FCF margin-0%0.0pp

Returns & leverage

See full

Return on equity-2.4%-21.9pp

Debt / equity0.1×0.0×

Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's contingent consideration fair value adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CareDx's contingent consideration fair value adjustments?: CareDx (CDNA) reported contingent consideration fair value adjustments of $0 in Q1 2026.
How has CareDx's contingent consideration fair value adjustments changed year-over-year?: CareDx's contingent consideration fair value adjustments decreased by 100.0% year-over-year, from $46K to $0.
What is the long-term trend for CareDx's contingent consideration fair value adjustments?: Over 2 years (2023 to 2025), CareDx's contingent consideration fair value adjustments has grown at a -48.8% compound annual growth rate (CAGR), from $2.68M to $703K.